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Summary
Human protectin (CD59) is an 18-20-kD membrane glycoprotein that restricts lysis of human
erythrocytes and leukocytes by homologous complement. By directly incorporating protectin
into membranes of heterologous cells we observed that protectin did not prevent perforin-mediated
killing, whereas complement killing was effectively restricted. Further, no significant enhancement
of cell-mediated killing or target killing by purified perforin was observed with anti-protectin
antibodies. Thus, in contrast with complement lysis, restriction of lysis by protectin does not
apply to cell-mediated killing.
r'rhecytolytic activity ofthe humancomplement (C) system
1 has been shown to be restricted by a novel 18-20-kD
glycoprotein, which is present on membranes of most cells
physiologically in contact with human blood. This molecule
has been called P-18 (1), MIRL (2), HRF20 (3), H-19 (4),
MEM-43 (5), or CD59 (6). To clarify the complexity ofused
designations the functionally descriptive name "protectin"
has recently been suggested (6a). Protectin is a glycosyl phos-
phatidyl inositol (GPI) anchored membrane glycoprotein,
which at the primary sequence level is homologous to the
mouse Ly-6 antigen family (6). Functionally, protectin has
been shown to act at the final stages of C membrane attack
complex (MAC) formation: by interacting with both the C8
and C9 components of MAC it was observed to inhibit the
C5b-8 complex accelerated insertion and oligomerization of
C9 in the lipid bilayer (6a).
Perforin isolated from cytotoxic T cells and NK cells has
a lytic activity that resembles that of the C system. Both
perforin and MAC have been shown to induce changes in
membrane potential and ring-like "lesions" on the target cell
membranes (7, 8). The lesions are believed to correspond to
tubular polymers of perforin or C9 molecules. At the pri-
mary sequence level perforin shows a limited (17-21%) ho-
mology to C9 as well as to other terminal C components
(C7, C8a, and C89), and perforin appears to share the puta-
tive membrane spanning region and the cysteine-rich epidermal
growth factor-type domain, but not the thrombospondin
or the low density lipoprotein receptor type domains with
the terminal C components (9).
In light of the structural and functional similarities be-
tween perforin and the MAC, it is of interest to know whether
common mechanisms exist that inhibit both C- and cell-
mediated cytotoxicity. The aim ofthis study was to discover
whether lysis by human perforin is restricted by protectin.
This question was addressed by studying the effects of an-
tiprotectin antibodies on cell-mediated killing and on per-
forin lysis of protectin-positive human cells and by comparing
the effect of human protectin incorporation on subsequent
lysis of nonhuman targets by perforin and complement.
Materials and Methods
Purred ComponentsandAntisera.
￿
Human protectin was isolated
from detergent-solubilized human E membranes using a rat anti-
CD59 mAb (YTH 53.1) Sepharose column (6). Partially purified,
functionally active human perforin was extracted from granules
ofhuman largegranular lymphocytes (9), and mouse perforin was
purified from the granules of the murine cytotoxic T cell line CTLIr
2B1/6(10). Complement C56 complexes and components C7, C8,
and C9 (11) were isolated as described. The rabbit polyclonal anti-
protectin antibody and the purified IgG fractions of the rat mono-
clonal antiprotectin (YTH53.1, IgG2b) and of the control anti-gly-
cophorin A (YTH89.1, IgG2b) antibodies wereprepared asdescribed
(6). Proteins were radiolabeled with tuI using the Iodogen method
(Pierce Chemical Co., Rockford, IL).
NK Cell-mediated Killing.
￿
The ability of the antiprotectin an-
tibodies to alter the sensitivity to lysis of the human NK sensitive
target K562 (a human erythroleukemia cell line; European Animal
Cell Collection, Porton Down, Wilts., U.K.) was examined in a
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PBMC by passage over a nylon-wool column to remove adherent
cells and either used fresh or following stimulation for 6 d with
20 U/ml of rIIr2 (ICN Biochemicals, High Wycombe, UK). The
K562 cellswere maintained in culture in RPMI 1640 (Gibco Labora-
tories, GrandIsland, NY) medium,whichwas supplemented with
10% (vol/vol) FCS. The cells were labeled with 100 ACi of "Cr
in 0.2 ml RPMI-10% FCS for 1 h, washed, resuspended into 10
ml RPMI-10% FCS, andincubatedfor afurther 1h.Afterwashing,
10°cells/50 P1 were mixedwith the appropriate antibody in atotal
volume of 150 gl and incubated for 15 min before the addition
of 2 x 105 effector cells/50 al. After 4 h at 37°C, 0.1 ml of the
supernatant was removedand countedin a gamma counter to de-
termine the percent cytotoxicity.
Lysis Assays.
￿
To study the effect of YTH53.1 and YTH89.1
IgGon human perforin-mediated lysis (9)of humanerythrocytes,
10' cells in 100 pl TBS-Cal+ (0.05 M Tris-HCI in physiological
saline, 5 mM CaC12, pH 7.4) were mixed andpreincubated (5 min
at 37°C)with 50 Al ofantibody dilution and subsequently incubated
(30 min at 37°C) with increasing doses of perforin. Lysis was de-
tected as hemoglobin releaseby absorbance at 412nm. Lysis ofK562
cells was tested after similar pretreatment with the antibody by
incubating (60 min at 37°C) the cells in the presence of various
concentrations of mouse perforin. To observe the effects of anti-
body on C lysis antibody (or buffer), pretreated K562 cells were
mixed with dilutions of fresh human serum and CVF (25 Irg/ml)
andincubatedfor 1 h at 37°C. Cell lysiswas determined as release
of lactate dehydrogenase (LDH).
Incorporation of 'Z1-Protectin into Cell Membranes.
￿
Purified pro-
tectin wasincorporated into membranesofguinea pig(GPE), rabbit,
and mouse erythrocytes by incubating (1 h at 37°C) 108 cells/tube
with increasing amounts of I'll-labeled protectin in TBS, 0.0005%
Lubrol PX. Cells were washed twice with TBS and counted for
radioactivity. Thenumber ofincorporated protectinmoleculesper
cell was calculated on the basis of the known specific activity of
the labeled preparation. Control cells of each species were treated
similarly with radiolabeled sheep anti-rabbit IgG in an equivalent
amount of detergent.
Perforin lysis of heterologous red cells with varying amounts
of incorporated "III-protectin was performed by incubating (30
min at +37°C) 0.25 x 108 cells/tube with perforin in TBS-Ca2+ .
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The K562 cells were pretreated with the YTH53.1 antibody (", /)
tions of either mouse perforin (original, 1 gg/ml; ", O) or of fresh
determined as LDH release.
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Figure 1.
￿
The effect of rat
anti-CD59 (antiprotectin) rnAb
(YTH53.1) and anti-glycopro-
tein A antibody (YTH89.1) on
killing of the 5'Cr-labeled K562
erythroleukemia cells by rIL2-
activated human PBMC. The
E/T ratio was 20:1 and killing
was determined after a 4-h in-
cubation at 37*C.
The amount of theperforin preparation used was adjusted to give
50% lysis ofunincorporated cells. ForC-mediated killing(reactive
lysis) 0.25 x 108 cells with vLrying amounts of incorporated ''SI-
protectinwere mixedwith C56(8.4 Ag) andhuman EDTA plasma
(final dilution 1:4 in a total volume of 100 pl) as a source of late
C components (C7, C8, and C9). Possible nonspecific effects of
protectinincorporation or ofantibodies were controlled by studying
red cell lysis by melittin and saponin (BDH, Poole, UK).
Results
Theanti-CD59 (antiprotectin) mAbYTH53.1, whichpre-
viouslyhasbeen shown to enhance reactive lysis (6), did not
have any detectable effect on killing of the K562 target cells
by I162-activated humanperipheral bloodNK cells (Fig. 1) .
K562 cells, which by FACS analysis were found to express
protectin on their surface, were lysed to the same extent in
thepresence of theantiprotectin or the isotype-matched control
antibody, and no dose-responseeffects of the antibodies could
be detected. The same result was obtained when fresh pe-
ripheral blood nonadherent mononuclear cells were used as
effector cells or when the human NK insensitive B cell lym-
phoma Raji was used as a target (not shown).
NK cell cytotoxicity is not mediated by perforin alonebut
involves other factors. Therefore, we analyzed whether the
YTH53.1 antibody has any effects in direct perforin killing
assays. As shown in Fig. 2 a, the YTH53.1 IgG appeared
Figure 2.
￿
The effect of the
YTH53.1 (antiprotectin) antibody
on perforin-mediated lysis of human
erythrocytes (a) or K562 erythro-
leukemia cells (b). (a) Human RBCs,
2 x 107 cells/tube (in TBS-Cat+),
were mixed with increasing con-
centrations of partially purified
human perforin in the presence of
the YTH53.1 (") or control (O;
YTH89.1, antiglycophorin) antibody
at 125 14g/ml or buffer (TBS; p).
Lysis was assessed as hemoglobin re-
lease (A412) after a 30-min incuba
tito
￿
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tion at 37°C. Means of triplicate
determinations are shown. The
Perforin/serum
￿
dilution
￿
effect of YTH53.1 antibody on lysis
of K562 cells by mouse perforin.
or Hepes buffer (O, 0) and incubated in the presence of indicated dilu-
normal human serum (NHS) plus CVF (N, [1). Lysis of K562 cells was
K562to slightly enhance human red cell lysis by partially purified
humanperforin as compared with the control antibody. When
a rabbit polydonal antiprotectin antibody was tested in a similar
assay, no enhancement of human red cell lysis could be ob-
served. Using highly purified mouse perforin, we could not
see any effect of the YTH53.1 IgG on lysis of human red
cells (not shown) or of the nucleated K562 cells (Fig. 2 b).
In all these assays the amounts of antibodies used caused a
clear-cut enhancement of C lysis.
To analyze directly the effects ofprotectin on perforin- and
C-mediated killing, the purified membrane form ofprotectin
was incorporated into membranes of erythrocytes from three
different species: guinea pig (GPE), rabbit, and mouse. On
the basis of the known specific radioactivity of 1251-protectin
it was calculated that maximally 6,500 molecules had become
bound per cell. The degree of incorporation did not con-
siderably differ between the three species.
As shown in Fig. 3 a, the incorporated human protectin
converted the normally C-sensitive GPEs into C resistant cells,
but no change in the sensitivity to lysis by human (Fig. 3
a) or mouse perforin (Fig. 3 b) was observed upon incorpora-
tion. The pattern was similar with cells from the two other
species (rabbit and mouse) studied (not shown). Thus, pro-
tectin lacked a restrictive effect upon killing by perforin regard-
less of whether the latter was of human or murine origin.
Discussion
Protectin (CD59) is a recently discovered potent MAC in-
hibiting factor (1-3, 6). In this study we have analyzed whether
protectin is also capable of preventing lysis by perforin, which
is an important cytolytic mediator in cell-mediated killing.
Human perforin is nonspecific in its killing function (12).
A possible explanation for this nonspecificity is that the target
GPE
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Figure 3.
￿
The effect of protectin
incorporation on perforin and C
lysis. (a) Purified human protectin
was incorporated into membranes of
guinea pig erythrocytes (GPE) as de-
scribed in Materials and Methods.
For C-mediated killing ("), 0.25 x
108 cells were mixed with C56 and
human EDTA plasma (final dilution
1:4 in TBS) as a source of late C
components (C7, C8, and C9).
Cell lysis was determined as hemo-
globin release (412 nm) after a 10-
min incubation at 37°C. For per-
1/10
￿
n
￿
forin lysis (O) 0.5 jug of partially
purified human perforin was mixed
Mouse perforin dilution
￿
with 0.25 x 108 cells in TBS-Ca2+
and incubated for 30 min at 37°C.
The effect of incorporated protectin on hemolysis is expressed as percentage inhibition of initial hemolysis in the absence of incorporated pro-
tectin. (b) The effect of protectin incorporation on GPE lysis by mouse perforin. The sensitivity of GPEs carrying "2,500 protectin molecules
per cell (") to lysis by indicated amounts of mouse perforin was compared with GPE with no incorporated protectin (O). Original perforin
concentration was 1 Aglml. Each point represents a mean of triplicate determinations. Lysis was measured by l4b release at 412 nm.
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(or receptor) molecule for perforin is phosphorylcholine (13),
an almost ubiquitous membrane constituent. Target recog-
nition by C is more complex. The lytic molecule C9 does
not by itself insert into the membrane, but requires the pre-
assembly of the C5b-8 complex. Formation of the C5b-8 com-
plex involves several steps, some of which are influenced by
specific control factors on the membrane.
The rat anti-CD59 mAb YTH53.1 has proved a useful tool
to neutralize the C lysis-restricting effect of protectin both
on human red cells and on nucleated cells (6, 6a, Rooney,
I.A., A. Davies, S. Meri, J.D. Williams, D. Griffiths, and
B.P. Morgan; manuscript submitted for publication). In con-
trast to its effects in C lysis, the YTH53.1 IgG did not en-
hance NK cell-mediated cellular cytotoxicity (Fig. 1). In di-
rect lysis assays with human, but not with mouse, perforin
(Fig. 2) this antibody had a slight lysis-enhancing effect, al-
though quantitatively this effect was much smaller than that
observed in C lysis. The possibility of a nonspecific lysis-
enhancing effect of the antibody was excluded in experiments
using melittin or saponin as lytic agents.
To assess more directly the differential role of protectin
in C- and perforin-mediated lysis, purified human protectin
was incorporated into membranes oferythrocytes from three
different heterologous species. Results of this experiment (Fig.
3) clearly illustrate the lack of any significant effect of pro-
tectin in perforin lysis. Also, neither restriction nor enhance-
ment of melittin or saponin lysis was observed with incor-
porated protectin.
Taken together these results show that protectin is primarily
a MAC inhibitor and has no significant protective role against
perforin lysis. Our results thus confirm recent studies that
suggest that GPI-linkedglycoproteins are not involved in con-
trol ofcell-mediated killing (9, 12, 14, 15). The mechanisms
of protection of the killer cells themselves against perforin
lysis are still unknown.References
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